Literature DB >> 12697728

Coordinated tumor immunity.

Glenn Dranoff1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12697728      PMCID： PMC152946          DOI： 10.1172/JCI18359

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  15 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

Authors:  M H Chang; C J Chen; M S Lai; H M Hsu; T C Wu; M S Kong; D C Liang; W Y Shau; D S Chen
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

4.  DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

Authors:  S Rovero; A Amici; E Di Carlo; R Bei; P Nanni; E Quaglino; P Porcedda; K Boggio; A Smorlesi; P L Lollini; L Landuzzi; M P Colombo; M Giovarelli; P Musiani; G Forni
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.

Authors:  M D Pegram; A Lipton; D F Hayes; B L Weber; J M Baselga; D Tripathy; D Baly; S A Baughman; T Twaddell; J A Glaspy; D J Slamon
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

6.  A controlled trial of a human papillomavirus type 16 vaccine.

Authors:  Laura A Koutsky; Kevin A Ault; Cosette M Wheeler; Darron R Brown; Eliav Barr; Frances B Alvarez; Lisa M Chiacchierini; Kathrin U Jansen
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

Review 7.  The innate immune response to tumors and its role in the induction of T-cell immunity.

Authors:  Andreas Diefenbach; David H Raulet
Journal:  Immunol Rev       Date:  2002-10       Impact factor: 12.988

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  New paths in human cancer serology.

Authors:  L J Old; Y T Chen
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

10.  Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice.

Authors:  P Nanni; G Nicoletti; C De Giovanni; L Landuzzi; E Di Carlo; F Cavallo; S M Pupa; I Rossi; M P Colombo; C Ricci; A Astolfi; P Musiani; G Forni; P L Lollini
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307
View more
  6 in total

Review 1.  Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.

Authors:  E M Tan; F-D Shi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

2.  The human cancer antigen mesothelin is more efficiently presented to the mouse immune system when targeted to the DEC-205/CD205 receptor on dendritic cells.

Authors:  Bei Wang; Janelle M Y Kuroiwa; Li-Zhen He; Anna Charalambous; Tibor Keler; Ralph M Steinman
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

3.  WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.

Authors:  Qihang Yuan; Qi Zhou; Jie Ren; Guan Wang; Chunlai Yin; Dong Shang; Shilin Xia
Journal:  Cancer Med       Date:  2021-05-12       Impact factor: 4.452

4.  Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression.

Authors:  Xiulong Xu; Geetha S Rao; Veronika Groh; Thomas Spies; Paolo Gattuso; Howard L Kaufman; Janet Plate; Richard A Prinz
Journal:  BMC Cancer       Date:  2011-05-23       Impact factor: 4.430

5.  Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells.

Authors:  Marion Dajon; Kristina Iribarren; Florent Petitprez; Solenne Marmier; Audrey Lupo; Mélanie Gillard; Hanane Ouakrim; Navas Victor; Di Bartolo Vincenzo; Pierre Emmanuel Joubert; Oliver Kepp; Guido Kroemer; Marco Alifano; Diane Damotte; Isabelle Cremer
Journal:  Oncoimmunology       Date:  2018-10-11       Impact factor: 8.110

6.  Elevation of inducible nitric oxide synthase and cyclooxygenase-2 expression in the mouse brain after chronic nonylphenol exposure.

Authors:  Yan-Qiu Zhang; Zhen Mao; Yuan-Lin Zheng; Bao-Ping Han; Ling-Tong Chen; Jing Li; Fei Li
Journal:  Int J Mol Sci       Date:  2008-10-24       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.